Rare Kidney Diseases Market Research Report by 2022, Forecast till 2035

Driven by the increased adoption and rising unmet need associated with rare kidney disorders, industry stakeholders have made significant investments to enable the development of novel drug candidates

For more information, please click on the following link:
https://www.rootsanalysis.com/....reports/rare-kidney-

Genotoxicity / Mutagenicity Testing Service Providers - Market Landscape

Genotoxicity refers to the evaluation of detrimental effects of chemical or physical agents on the genetic processes and related hereditary material of living cells.

During our research, we were able to identify the presence of more than 80 players that are engaged in offering services across the globe.

Majority of the genotoxicity / mutagenicity testing service providers (40%) engaged in this domain were established pre-1991. This is indicative of the growing interest of stakeholders in this domain. Examples of recently established companies include (post-2010, in alphabetical order) Admescope (2011), Anax Laboratories (2012) and Aragen Life Sciences (2021). Additionally, 14% companies have entered this domain between 1991 and 2000, indicating that the market is driven by efforts of well-established players as well. At present, more than 80 players offer a variety of assays, such as Ames assay, micronucleus assay, chromosomal aberration test, genetic mutation assay and comet assay, which can be used to evaluate the genetic toxicity of a substance.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/....reports/genotoxicity

Further, it was observed that majority of service providers are based in Asia-Pacific (49%), followed by players based in North America (30%) and Europe (21%). The current market landscape is dominated by the presence of mid-sized organization (43%). Notable examples include (in alphabetical order) Anax Laboratories and CSIR – Indian Institute of Toxicology.

Further, genotoxicity / mutagenicity testing service providers, focuses on providing services to a wide range of industries, primarily includes healthcare industry (96%) followed by chemical industry (46%). It is worth noting that organizations such as Cadila Pharmaceuticals and DigilanceBio offer services for all types of industries.

According to our proprietary scoring criteria, in North America, Crown Biosciences has emerged to be relatively superior, in terms of company strength. The firm offer service through in vivo type of assay.

Further, Charles River Laboratories emerged as one of the prominent player offering both in vivo and in vitro assays. The platform has capability to offer services through different assay(s) / test(s) including Ames Test, micronucleus test, chromosomal aberration test, genetic mutation test and comet assay.


For additional details, please visit https://www.rootsanalysis.com/....reports/genotoxicity

You may also be interested in the following titles:

1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035
2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]